Covidien (COV) Tops Q4 EPS by 13c

Covidien (NYSE: COV) reported Q4 EPS of $1.15, $0.13 better than the analyst estimate of $1.02. Revenue for the quarter came in at $2.73 billion versus the consensus estimate of $2.69 billion.

For earnings history and earnings-related data on Covidien (COV) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c